2023 was a big year for CRISPR-based gene editing but challenges remain

How CRISPR gene editing could help treat Alzheimer’s

CRISPR-based gene editing therapy approved by the FDA for the first time

FDA approves a CRISPR-based medicine for treatment of sickle cell disease- In historic decision